Factor Xa inhibitors versus vitamin K antagonist in morbidly obese patients with venous thromboembolism: a systematic review and meta-analysis

INTRODUCTION: Guidelines have endorsed non-vitamin K antagonist oral anticoagulants (NOACs), consisting of factor Xa inhibitors (xabans) and direct thrombin inhibitors, as the first line of treatment in venous thromboembolism (VTE) and atrial fibrillation. However, morbidly obese patients were under...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Dae Yong, An, Seokyung, Arif, Abdul Wahab, Sana, Muhammad Khawar, Vij, Aviral
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945392/
https://www.ncbi.nlm.nih.gov/pubmed/36814196
http://dx.doi.org/10.1186/s12872-023-03067-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945392/
https://www.ncbi.nlm.nih.gov/pubmed/36814196
http://dx.doi.org/10.1186/s12872-023-03067-4

Ejemplares similares